Insights On Manufacturing Logistics

  1. Planning For Scale-Up 5/21/2026

    From rapid early-stage production to scalable commercialization, discover the packaging and continuity challenges companies face as they prepare for launch.

  2. Understanding The Regulatory Landscape For Ophthalmic Drug Products 5/14/2026

    Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.

  3. Minimizing Particulate Risk 5/13/2026

    While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.

  4. Protecting Your Drug Product 5/13/2026

    With patient lives depending on every dose, even minor vulnerabilities in containment or delivery systems can have serious consequences for product integrity and patient outcomes.

  5. Establishing A Container Closure System 5/13/2026

    As a trusted partner to both established and emerging drug developers, we support the safe, effective containment and delivery of life-saving and life-enhancing medicines.

  6. Start Packaging Development Early 5/12/2026

    To avoid costly delays later in the product lifecycle, it is essential to plan for key variables early and select container closure systems with confidence from the outset.

  7. USP Draft Chapters On CCS: What You Need To Know 5/12/2026

    Learn why it's important to stay aligned with evolving Annex 1 expectations to support sterility assurance, regulatory compliance, and patient safety across sterile drug manufacturing operations.

  8. USP <788> Revisions And Why Packaging Matters More Than Ever 5/12/2026

    Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.

  9. Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality 5/12/2026

    Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.

  10. Annex 1 FAQs: Responding To The 2022 Revision 5/11/2026

    Viewing the Annex 1 revision as a natural extension of current habits, rather than a burden, allowed for a seamless transition. Since contamination control was already standard, the update simply validated existing excellence.